Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 173

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice

STAPLETON, JOHN A., RUSSELL, MICHAEL A. H., FEYERABEND, COLIN, WISEMAN, SIMON M, GUSTAVSSON, GUNNAR, SAWE, URBAIN, WISEMAN, DEBBIE · 2006 · Addiction

Abstract

The transdermal nicotine patch has proved an effective aid to smoking cessation. The ease of securing good compliance gives it a potential advantage over nicotine gum as an adjunct to brief advice and support in primary care settings where the major public health impact is obtained. In a preliminary report of half the sample of a randomized placebo controlled trial, we showed the patch to be effective in a general practice setting. We report here the definitive results of the full sample, including dose effects, predictors of outcome and other issues of theoretical and practical interest. A total of 1200 heavy smokers (> or = 15 per day), attending 30 general practices in 15 English counties received brief GP advice, a booklet and 16 hours per day patch treatment for 18 weeks. Dose increase and abrupt vs. gradual reduction of patch dosage were also randomized and follow-ups conducted at 1, 3, 6, 12, 26 and 52 weeks. Outcome was measured by self-reported complete abstinence from week 3 to 52 with biochemical validation at all follow-up points. Nicotine patch treatment doubled the rate of continuous abstinence up to 1 year (nicotine 9.6%, placebo 4.8%, p < 0.01); it most likely worked by reducing withdrawal symptoms. It enhanced cessation during the first week and reduced relapse during the second week. The dose increase after week 1 produced no sustained increase in cessation. Gradual reduction was no better at preventing relapse than abrupt withdrawal of patches after week 12. Whether relapse would have increased by ending treatment at some point between weeks 3 and 12 was not tested. Although pre-treatment dependence on cigarettes was prognostic of failure, the patches were equally helpful to both highly and less dependent smokers. Patches were particularly helpful to smokers with pre-treatment subclinical dysthymic symptoms. All but one of the 96 subjects eventually achieving long-term abstinence in the study quit during the first week of cessation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1360-0443.1995.901316.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 31

  1. US Department of Health and Human Services, 1988, Nicotine addiction: A report of the Surgeon General
  2. Jarvis M. J., 1989, International Review of Psychiatry, 1, 139, 10.3109/09540268909110390 · DOI
  3. Foulds J., 1993, Addiction, 88, 1473, 10.1111/j.1360-0443.1993.tb03132.x · DOI
  4. 10.1016/S0140-6736(94)90933-4 · DOI · Paper page
  5. Tang J. L., 1994, British Medical Journal, 308, 21, 10.1136/bmj.308.6920.21 · DOI · Paper page
  6. 10.1016/0140-6736(92)91403-U · DOI · Paper page
  7. 10.1001/jama.269.10.1268 · DOI
  8. Jarvis M. J., 1982, British Medical Journal, 285, 537, 10.1136/bmj.285.6341.537 · DOI · Paper page
  9. Russell M. A. H., 1994, Future Directions in Nicotine Replacement Therapy, 15
  10. Russell M. A. H., 1979, British Medical Journal, 2, 231, 10.1136/bmj.2.6184.231 · DOI · Paper page
  11. Slama K., 1990, British Medical Journal, 300, 1707, 10.1136/bmj.300.6741.1707 · DOI
  12. Russell M. A. H., 1983, British Medical Journal, 287, 1782, 10.1136/bmj.287.6407.1782 · DOI · Paper page
  13. Russell M. A. H., 1987, British Medical Journal, 295, 1240, 10.1136/bmj.295.6608.1240 · DOI
  14. Jamrozik K., 1984, British Medical Journal, 289, 794, 10.1136/bmj.289.6448.794 · DOI
  15. Lam W., 1985, Lancet, 27
  16. Russell M. A. H., 1993, British Medical Journal, 306, 1308, 10.1136/bmj.306.6888.1308 · DOI · Paper page
  17. 10.1007/BF00432717 · DOI
  18. 10.1016/0091-7435(86)90044-7 · doi:10.1016/0091-7435(86)90044-7
  19. ICRF General Practice Research Group, 1993, British Medical Journal, 306, 1304, 10.1136/bmj.306.6888.1304 · DOI
  20. 21. E. Goddard(1990 ) Why Children Stan Smoking , pp. 8 -11 (OPCS, London, HMSO).
  21. Tonnesen P., 1991, New England Journal of Medicine, 325, 311, 10.1056/NEJM199108013250503 · DOI · Paper page
  22. Office of Population Censuses and Surveys, 1994, General Household Survey 1992
  23. Russell M. A. H., 1991, Tobacco and Health 1990: The Global War, 49
  24. 10.1001/jama.266.22.3133 · DOI
  25. 10.1001/jama.271.8.595 · DOI
  26. ICRF General Practice Research Group, 1994, British Medical Journal, 308, 1476, 10.1136/bmj.308.6942.1476 · DOI
  27. 10.1016/S0140-6736(89)91671-1 · DOI · Paper page
  28. 10.1016/0005-7967(76)90065-6 · DOI
  29. 10.1037//0022-006X.61.5.761 · DOI · Paper page
  30. Glassman A. H., 1993, American Journal of Psychiatry, 150, 546, 10.1176/ajp.150.4.546 · DOI · Paper page
  31. Russell M. A. H., 1974, Journal of the Royal Statistical Society, A, 137, 313, 10.2307/2344953 · DOI · Paper page

Cited by

See all 173

Metadata

Authors
STAPLETON, J. A., RUSSELL, M. A. H., FEYERABEND, C., WISEMAN, S. M., GUSTAVSSON, G., SAWE, U., & WISEMAN, D.
Venue
Addiction
Publisher
Wiley
Published
2006-01-24
Volume
90
Issue
1
Pages
31-42
ISSN
0965-2140 (ISSN-L)
OpenAlex
W2035700940
Cited by
173
References
3
FWCI
5.43
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1 (tdm, 7548 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. https://app.cochat.ai/papers/10.1046/j.1360-0443.1995.901316.x
The paper
STAPLETON, J. A., RUSSELL, M. A. H., FEYERABEND, C., WISEMAN, S. M., GUSTAVSSON, G., SAWE, U., & WISEMAN, D. (2006). Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction. https://doi.org/10.1046/j.1360-0443.1995.901316.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.